Key Takeaways

  • Actinide became the first startup to enrich uranium and produce High-Assay Low-Enriched Uranium (HALEU) in the United States.
  • The company modernized the Manhattan Project Calutron, using superconducting zero-power magnets to eliminate the massive energy consumption that made electromagnetic isotope separation impractical decades ago.
  • Before supplying commercial reactor fuel, Actinide generated early revenue by shipping medical isotopes priced at $30,000 per gram to Oklo.
  • Operating under Category 2 nuclear regulatory standards allows Actinide to build domestic enrichment capability and cut Western dependence on Russian nuclear supply chains.

Rebuilding the Manhattan Project Calutron

When the Department of Energy points out that the United States has no domestic supply of High-Assay Low-Enriched Uranium, next-generation fission reactors cannot turn on. Advanced nuclear designs require HALEU to run, yet Western power developers have remained dependent on Russian suppliers for enriched feedstock.

Actinide co-founders Robert Mendelsohn and Eric Olszewski chose an unexpected path to solve the bottleneck: they looked backward eighty years.

“We have a machine called the Calutron which was originally invented by Nobel laureates for the Manhattan project,” Mendelsohn explained. “So, they've already delivered for our country once before.”

The Calutron uses electromagnetic isotope separation to pull isotopes apart. In the 1940s, Oak Ridge National Laboratory ran thousands of Calutrons around the clock to refine uranium. The machines worked, but their electromagnets swallowed staggering amounts of electricity. When gas centrifuges arrived, the industry abandoned Calutrons because the power bill was simply too high.

Mendelsohn and Olszewski realized modern physics changes the math entirely. “Now magnets don't consume power if they're superconducting for instance,” Mendelsohn said. “And so it's very rare in the engineering fields that you'll find the major problem can actually go to zero.”

By swapping power-hungry copper coils for superconducting magnets, Actinide dropped the Calutron's primary operating cost to near zero. A technology that was shelved for extreme inefficiency suddenly became commercially viable.

Finding Cash Flow in $30,000 Grams

Building nuclear enrichment facilities usually takes billions of dollars and decades of regulatory permits. Startups rarely survive that waiting period without near-term revenue.

Actinide bypassed the standard nuclear trap by pointing their machines at higher-margin, smaller-volume markets first.

“Some of the first refined atoms that we made were for the medical industry,” Olszewski noted. “They go for about $30,000 per gram. Which is like a paperclip worth of material for you Patriots out there. And we delivered that to Oklo isotopes.”

Refining medical isotopes proved the enrichment hardware worked in production, brought in immediate cash, and demonstrated compliance with Category 2 nuclear regulatory standards. Instead of waiting years for full-scale commercial reactor fuel contracts, Actinide shipped physical product to paying buyers.

“We were indeed the first startup in history to enrich uranium and produce Halo,” Olszewski said. “It's the next gen fuel for next gen reactors. And it's something that the department of energy says that you cannot get presently in the United States. There's no supply.”

What to Do With This

Audit your industry's abandoned technical archives from thirty or fifty years ago. Look for solutions that failed only because of a single prohibitive input cost, like compute, power, or material fabrication. If modern components eliminate that exact cost constraint, build a prototype using the vintage blueprint before writing novel software from scratch.